Çaliskan Selahattin, Kaba Selçuk, Koca Orhan, Öztürk M. Ishak
Department of Urology, Hitit University, Çorum Training and Research Hospital, Turkey.
Department of Urology, Haydarpasa Numune Training and Research Hospital, Turkey
J Coll Physicians Surg Pak. 2017 Feb;27(2):97-100.
The current is study aimed to assess the patients who underwent radical prostatectomy for prostate cancer and investigate the association between prostate size and adverse outcomes at final pathology.
Comparative, descriptive study.
Haydarpasa Numune Training and Research Hospital, Turkey, from January 2008 to January 2016.
The patients treated with open radical prostatectomy for prostate cancer were reviewed. Patient characteristics including prostate specific antigen (PSA), free PSA levels, age, biopsy, and radical prostatectomy results were recorded. The patients whose data were complete or prostate weight was equal to or less than 80 gm, were included in the study. Patients with <40 gm prostate weight was in group 1 and the patients in group 2 had a prostate weight from 40 to 80 gm. High grade prostate cancer was defined to have a Gleason score between 7 or higher at biopsy and final pathology. Pathology and biopsy results were compared within groups. MedCalc Statistical Software demo version was used for statistical analyses.
There were 162 patients in this study. Of these, 71 (43.82%) patients were in group 1 and 91 (56.17%) patients were in group 2. The age ranged from 49 to 76 years. Mean value of 62.70 ±6.82 and 65.82 ±5.66 years in group 1 and 2, respectively. Fifty (70.42%) and 68 patients (74.74%) had a Gleason score of 6 in group 1 and 2, respectively. Organconfined disease was reported in 53 patients (74.64%) in group 1 and in 78 patients (85.71%) in group 2. Gleason score concordance between biopsy and prostatectomy was reported in 61 patients (67.03%) and downgrading was detected in 4 patients (4.4%) in group 2. The median tumor volume of the patients was 4.47 cm3 in group 1 and 6 cm3 in group 2 (p=0.502). High grade prostate cancer was reported in 52.11% and 45.05% of the patients in groups 1 and 2, respectively at final pathology (p=0.373).
The present study demonstrated that smaller prostates are more likely to compose higher percentage of the high grade prostate cancer, local advanced disease, and the Gleason upgrading. The positive surgical margin rate is higher in patients with small prostates when it is compared with the other patients.
本研究旨在评估接受前列腺癌根治性前列腺切除术的患者,并调查前列腺大小与最终病理检查时不良结局之间的关联。
比较性描述性研究。
土耳其海达尔帕萨努穆内培训和研究医院,2008年1月至2016年1月。
对接受开放性前列腺癌根治性前列腺切除术的患者进行回顾性研究。记录患者特征,包括前列腺特异性抗原(PSA)、游离PSA水平、年龄、活检结果和根治性前列腺切除术结果。数据完整或前列腺重量等于或小于80克的患者纳入研究。前列腺重量<40克的患者为第1组,第2组患者的前列腺重量为40至80克。高级别前列腺癌定义为活检和最终病理检查时Gleason评分在7分及以上。对组内的病理和活检结果进行比较。使用MedCalc统计软件演示版进行统计分析。
本研究共有162例患者。其中,第1组71例(43.82%),第2组91例(56.17%)。年龄范围为49至76岁。第1组和第2组的平均年龄分别为62.70±6.82岁和65.82±5.66岁。第1组和第2组分别有50例(70.42%)和68例(74.74%)患者的Gleason评分为6分。第1组53例(74.64%)和第2组78例(85.71%)患者报告有器官局限性疾病。第2组61例(67.03%)患者的活检和前列腺切除术Gleason评分一致,4例(4.4%)患者出现降级。第1组患者的肿瘤体积中位数为4.47立方厘米,第2组为6立方厘米(p=0.502)。最终病理检查时,第1组和第2组分别有52.11%和45.05%的患者报告为高级别前列腺癌(p=0.373)。
本研究表明,较小的前列腺更有可能在高级别前列腺癌、局部晚期疾病和Gleason评分升级中占更高比例。与其他患者相比,前列腺较小的患者手术切缘阳性率更高。